Skip to main navigation Skip to search Skip to main content

Understanding the Regulatory Pathways Used to Develop, Evaluate, Authorize, and Approve New Drugs and Vaccines in the United States

  • Joseph B. Domachowske

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

The United States (U.S.) Food and Drug Administration (FDA) oversees the safety and quality of drugs and vaccines that are used in the U.S. Administration of the FDA falls under the jurisdiction of the U.S. Department of Health and Human Services (HHS). The regulatory oversight of the FDA is complex and comprehensive, requiring the various roles and responsibilities to be divided across six main centers. The activities of two of these centers, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) are the primary focus of this review.

Original languageEnglish
Pages (from-to)S93-S102
JournalJournal of the Pediatric Infectious Diseases Society
Volume13
DOIs
StatePublished - Aug 1 2024

Keywords

  • CBER
  • CDER
  • FDA approval process
  • phases of clinical trials
  • vaccine development

Fingerprint

Dive into the research topics of 'Understanding the Regulatory Pathways Used to Develop, Evaluate, Authorize, and Approve New Drugs and Vaccines in the United States'. Together they form a unique fingerprint.

Cite this